Clinical Trials in Cleveland

Showing 4521-4540 of 19,775 trials

LUng voluMe reductIoN by DuAl ENergy CT Evaluation (LUMINANCE) Study

NCT05816239

The purpose of this research study is to see if a special CT scan (dual-energy CT) provides useful information in patients undergoing bronchsoscopic lung volume reduction (valve placement for emphysema). The investigators will enroll up to 30 participants in this study from University Hospitals Cleveland Medical Center. All of the participants from this study will undergo their valve procedure at University Hospitals Cleveland Medical Center.

Lung Perfusion

Sameer Avasarala13 participantsStarted Feb 2023

Cleveland, Ohio, United States

COMPLETEDPhase 2< 1 mile

Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

NCT06308614

The goal of this clinical trial is investigating estetrol (E4) in women after menopause, suffering from sexual arousal disorder. The main question it aims to answer is: is 20 mg estetrol monohydrate effective in the treatment of sexual arousal disorder in women after their menopause. Participants will visit the clinic 7 times and complete a daily diary while receiving estetrol or placebo for 12 weeks. Placebo is a pill that looks the same as estetrol but has no active ingredient. Researchers will compare estetrol and placebo to see if estetrol has an effect on the sexual arousal of the participants.

Sexual Dysfunction, Physiological

Estetra82 participantsStarted Jan 2024

Mesa, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +21 more locations

LUng voluMe reductIoN by DuAl ENergy CT Evaluation (LUMINANCE) Study

Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

Find Trials by Condition in Cleveland

INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study

The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

Open-Label Extension Study of Setmelanotide

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

MR Image Synthesis With Low Gadobutrol Dose and AI

DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).

A Study of Abemaciclib in Recurrent Glioblastoma

A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

InBody Band 3 Fitness Tracker to Improve Health Outcomes and Quality of Life in Black Prostate Cancer Survivors

Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM